Mymetics Corp (MYMX)

[Work Harder]

Imugene acquired 100% of Biolife Science

PEV6, has been licensed out to BioLife Science

PEV3, has been outlicensed to Mymetics and is in late-stage clinical development. Mymetics also holds a license to a Phase I-stage HIV vaccine program.

Swiss firm Pevion’s virosome technology is a carrier and adjuvant system designed specifically for subunit vaccines, and has already been used for development of the marketed vaccines Epaxal® and Inflexal® V (both marketed by Crucell).

https://www.genengnews.com/topics/drug-discovery/csl-negotiates-option-to-pevions-candida-vaccine-for-australia-and-new-zealand/

which we know is history

https://www.researchgate.net/publication/8929756_Development_of_a_SARS_vaccine_an_industrial_perspective_on_the_global_race_against_a_global_disease

hmmmm

Maybe worth that trip